Target intelligence / Profile preview

Mitoferrin-1 (SLC25A37)

Target
SLC25A37
Molecular classification
Transporter, Mitochondrial carrier superfamily
01

Overview

Mitoferrin-1 (encoded by the SLC25A37 gene) is a mitochondrial inner membrane transporter essential for importing ferrous iron (Fe2+) into the mitochondrial matrix, where this iron is required for the biosynthesis of heme and iron–sulfur (Fe-S) clusters[1][2][3]. Mitoferrin-1 is especially important in developing erythroid cells, where demand for mitochondrial iron is highest due to hemoglobin synthesis. Loss of function mutations in SLC25A37 can result in profound anemia and are embryonically lethal in animal models, while altered expression or regulation of the protein is linked with several human diseases involving impaired erythropoiesis and mitochondrial dysfunction. Mitoferrin-1 forms oligomeric complexes with the ABCB10 transporter and ferrochelatase, enabling efficient delivery of iron for heme synthesis. Although both mitoferrin-1 and its paralog mitoferrin-2 (SLC25A28) contribute to mitochondrial iron import, mitoferrin-1 is essential when iron demand is high, as in erythroid cells, and its dysfunction cannot be fully compensated by mitoferrin-2[1][2][3]. There are currently no clinically approved drugs targeting mitoferrin-1, but its central role in iron metabolism makes it a candidate for therapeutic research in disorders of mitochondrial iron homeostasis.

Other names
Mitoferrin-1MFRNMFRN1Mitochondrial iron transporter 1Mitochondrial solute carrier proteinSolute carrier family 25 member 37MSCMSCPHT015PRO1278PRO1584PRO2217
02

Mechanism of action

Not applicable, as no approved drugs directly target Mitoferrin-1. Potential mechanisms would involve inhibition or modulation of mitochondrial iron import, but this remains experimental[2][3].

03

Biological functions

Mitochondrial iron importIron homeostasisHeme biosynthesisIron–sulfur cluster assemblyErythroid cell differentiation
04

Disease associations

Anemia (including congenital sideroblastic anemia)Cancer (such as hepatocellular carcinoma, pancreatic cancer, some cancers via affected iron homeostasis)Diamond-Blackfan anemiaMyelodysplastic syndrome (subgroup with splicing factor mutations)Erythropoietic protoporphyriaOther disorders related to mitochondrial iron metabolism
05

Safety considerations

Potential for severe anemia or lethal disruption of erythropoiesis if function is inhibited or lost (as observed in animal knockout models and humans)Disrupted iron homeostasis can affect critical mitochondrial processes with wide-ranging systemic effectsRisk of off-target effects related to essential cellular iron handling[2][3]
06

Interacting drugs

None in clinical use or trials as direct inhibitors/activators. No established drugs targeting Mitoferrin-1 identified in curated databases or literature[1][2][3]. (Experimental modulation possible with gene silencing, CRISPR, small molecules in preclinical research.)
07

Biomarkers

Low or aberrant expression (mutation, splicing changes) used as research biomarkers for erythroid anemias, sideroblastic anemia, and certain cancers[2].

Beyond the preview

Go deeper on Mitoferrin-1 (SLC25A37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitoferrin-1 (SLC25A37).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call